ICD-10 category · Chapter XX · Y40-Y59
Y44 Adverse effects in therapeutic use, agents primarily affecting blood constituents
10 codes under Y44 in the South African Master Industry Table 2021, 9 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| Y44 | Adverse effects in therapeutic use, agents primarily affecting blood constituents | Heading only | — |
| Y44.0 | Adverse effects in therapeutic use, iron preparations and other anti-hypochromic-anaemia preparations | Valid · not as primary | — |
| Y44.1 | Adverse effects in therapeutic use, vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations | Valid · not as primary | — |
| Y44.2 | Adverse effects in therapeutic use, anticoagulants | Valid · not as primary | — |
| Y44.3 | Adverse effects in therapeutic use, anticoagulant antagonists, vitamin K and other coagulants | Valid · not as primary | — |
| Y44.4 | Adverse effects in therapeutic use, antithrombotic drugs [platelet-aggregation inhibitors] | Valid · not as primary | — |
| Y44.5 | Adverse effects in therapeutic use, thrombolytic drugs | Valid · not as primary | — |
| Y44.6 | Adverse effects in therapeutic use, natural blood and blood products | Valid · not as primary | — |
| Y44.7 | Adverse effects in therapeutic use, plasma substitutes | Valid · not as primary | — |
| Y44.9 | Adverse effects in therapeutic use, other and unspecified agents affecting blood constituents | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.